Nicholas J. Vogelzang, MD, FAnnual Meeting, FACP of Comprehensive Cancer Centers of Nevada explains why BRCA 1 and BRCA 2 genetic testing should be added to the guidelines for treating prostate cancer at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Should BRCA1 and BRCA2 Genetic Testing Be Added to Guidelines for Prostate Cancer–Yes
